To cross-validate CYB561D2 up-regulation, we explored expression data from REMBRANDT glioma [19] (total n = 524, Fig. 1D) and TCGA GBM (total n = 454, Fig. 1E) datasets. Here, CYB561D2 is linked to central nervous system cancer.